Bruno Sangro
Navarre Institute of Health Research(ES)Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas(ES)Clinica Universidad de Navarra(ES)Universidad de Navarra(ES)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, Liver Disease and Transplantation, Cholangiocarcinoma and Gallbladder Cancer Studies
Most-Cited Works
- → Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial(2017)4,261 cited
- → BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update(2021)3,953 cited
- → Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade(2014)2,678 cited
- → Hepatocellular carcinoma(2016)2,623 cited
- → Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma(2022)1,333 cited
- → Advances in immunotherapy for hepatocellular carcinoma(2021)1,299 cited